| __timestamp | Agios Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 72429000 |
| Thursday, January 1, 2015 | 35992000 | 78634000 |
| Friday, January 1, 2016 | 50714000 | 75374000 |
| Sunday, January 1, 2017 | 71124000 | 92157000 |
| Monday, January 1, 2018 | 114145000 | 93326000 |
| Tuesday, January 1, 2019 | 132034000 | 103132000 |
| Wednesday, January 1, 2020 | 149070000 | 110171000 |
| Friday, January 1, 2021 | 121445000 | 218817000 |
| Saturday, January 1, 2022 | 121673000 | 233827000 |
| Sunday, January 1, 2023 | 119903000 | 267194000 |
| Monday, January 1, 2024 | 156784000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Lantheus Holdings, Inc. and Agios Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Lantheus Holdings saw a remarkable 270% increase in SG&A expenses, peaking in 2023. In contrast, Agios Pharmaceuticals experienced a more modest 526% rise, with its highest expenses recorded in 2020.
These trends highlight the dynamic nature of the biotech industry, where strategic financial management can significantly impact a company's trajectory.
Breaking Down SG&A Expenses: Eli Lilly and Company vs Agios Pharmaceuticals, Inc.
Novo Nordisk A/S or Lantheus Holdings, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Agios Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Genmab A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Agios Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Perrigo Company plc
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Cost Management Insights: SG&A Expenses for Xenon Pharmaceuticals Inc. and Agios Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Catalyst Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.